Health

The “Momnibus” was originally introduced in March 2020 but got little traction because it was just days before the country was thrown full bore into the COVID-19 pandemic.

How long is the wait to hear back? Is it first-come, first-served? What about line-jumping? WHYY’s Health Desk Help Desk wondered too.

30-year-old Philadelphia FIGHT provides health care and coronavirus testing. It wants people to know it is not involved with the similarly named start-up.

New Castle County used $5.5 million of its federal coronavirus relief money to fund the laboratory at the university’s northern campus.

With vaccine still scarce, and eligibility differing from place to place, some people have easier access to "extra" doses than others. Careful, ethicists warn.

Some experts see an opportunity to refocus U.S. testing less on medical precision than on mass screening that they believe could save hundreds of thousands of lives.

“I’m worried about Super Bowl Sunday, quite honestly. People gather, they watch games together. We’ve seen outbreaks already from football parties."

Because of the priority schedule for early eligibility, the gender imbalance is likely to continue for a while.

Bogus reminder emails are going out because Philly Fighting COVID never shut down its scheduling system.

Some counties received less vaccine, but Mauldin says state officials have to distribute equitably.

New Jersey and New York were among the first states to report coronavirus cases in the spring when the pandemic surged in the Northeast.

Despite being among the most at risk, some lack transportation, access to chain pharmacies, and internet connections to get vaccine appointments.

Caregivers must take steps to make sure those with limited communication and social skills stay safe because other conditions put them at higher risk.

Pregnant Black women have a 50% increased risk of delivering before a full 40 weeks. The researchers will look at pandemic-era changes in prenatal care.

J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19, according to preliminary results from a massive international study.